Wyden’s Principles of Reform Include a US-Based Drug Pricing System

Senator Wyden is pushing for legislation that will reduce prescription drug prices, such as Biogen’s pricy Aduhelm. He’s noted that the United States needs to develop its own system, rather than relying on international drug prices. In contrast to pharma, he doesn’t expect regulations to impact innovation.

“Wyden on Monday emphatically rejected claims that negotiation would inevitably lead to fewer breakthroughs, arguing “industry overstates how innovative it is. It always equates innovation with the number of new treatments, regardless of whether they are me-too drugs or truly novel.” Read more here.

(Source: Jonathan Cohn, HuffPost, 6/22/21)